New method enables easier and faster detection of celiac disease antibodies

wheat
Credit: CC0 Public Domain

Point-of-care (POC) testing is a rapidly growing sector, bringing medical testing from central laboratories to where the patient is receiving care.

Researchers from the University of Helsinki have developed a novel coined RFS (Rapid FRET serodiagnostics) for the rapid on-site measurement of antibodies from patient samples. This technology could revolutionize the serodiagnosis of microbial, autoimmune and allergic disorders.

Now this team of researchers have applied the new concept for diagnostics of celiac disease.

Most patients are unaware of their celiac disease

Celiac disease is an autoimmune disorder typically presenting as non-specific gastrointestinal symptoms. It affects approximately 1 % of , with more than 90 % of patients undiagnosed. Even in affluent countries, more than half of celiacs are unaware of their disease. Delayed diagnosis is associated with impaired quality of life and persistent symptoms even after treatment.

Screening of celiac disease is recommended for patients with e.g. gastrointestinal symptoms or other as well as for the first-degree relatives of celiac patients. The screening test involves measurement of disease-specific antibodies from a .

Easy and faster detection of celiac disease antibodies

The researchers gathered samples from 70 celiacs at the Kuopio University Hospital, half from children and half from adults. Control samples from healthy donors were also collected. The samples were measured using the new assay and results compared with two currently used methods.

"The performance of the test was comparable to that of current methods. The prevailing method involves transporting the sample to a central laboratory and a multi-step procedure taking hours. With the new method, results can be achieved in less than half an hour by simply combining the sample and a reagent mix, waiting for a while and reading the result.", Juuso Rusanen, MD, explains. He continues:

"We hope our rapid method could lower the threshold for screening of and thus help overcome the vast underdiagnosis of this relatively common condition."

"Additionally, this is the first time the new method has been used for diagnostics of autoimmune disease. This is a promising result, and prompts the development of similar tests for diagnostics of other ," Rusanen points out.


Explore further

Celiac disease screening for family members

More information: Juuso Rusanen, Anne Toivonen, Jussi Hepojoki, Satu Hepojoki, Pekka Arikoski, Markku Heikkinen, Outi Vaarala, Jorma Ilonen and Klaus Hedman. LFRET, a novel rapid assay for anti-tissue transglutaminase antibody detection. PLOS One 2019, 14, e0225851; doi.org/10.1371/journal.pone.0225851
Journal information: PLoS ONE

Citation: New method enables easier and faster detection of celiac disease antibodies (2019, November 27) retrieved 8 December 2019 from https://medicalxpress.com/news/2019-11-method-enables-easier-faster-celiac.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments